Key regions: Europe, Germany, United States, Brazil, Australia
The Other OTC Pharmaceuticals market in Mozambique has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences in Mozambique have shifted towards self-medication and over-the-counter (OTC) products. This is driven by factors such as convenience, cost-effectiveness, and the increasing availability of information on healthcare and treatment options. Customers are increasingly seeking quick and accessible solutions for common ailments, and OTC pharmaceuticals provide a convenient and affordable option.Trends in the market reflect this changing customer preference. The market has seen a rise in the availability and variety of OTC pharmaceutical products. Pharmacies and drugstores have expanded their offerings to cater to the growing demand for self-medication. This trend is also supported by the increasing number of pharmacies and drugstores across the country, making OTC products more accessible to the population.Local special circumstances in Mozambique, such as the lack of healthcare infrastructure in rural areas, have further fueled the growth of the Other OTC Pharmaceuticals market. Limited access to healthcare facilities and healthcare professionals in these areas means that individuals often rely on self-medication for minor ailments. This has created a significant market opportunity for OTC pharmaceuticals.Underlying macroeconomic factors have also played a role in the development of the Other OTC Pharmaceuticals market in Mozambique. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and purchasing power. As a result, more individuals are able to afford OTC pharmaceuticals and are willing to spend on healthcare products and services.In conclusion, the Other OTC Pharmaceuticals market in Mozambique has experienced significant growth due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the availability of a wide range of OTC products, limited healthcare infrastructure in rural areas, and the country's economic growth have all contributed to the expansion of this market.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
